Department of Pharmacy and Social Pharmacy

Theses

2020/2021

Diploma theses

• Analysis of drug policy tools in public health insurance resources utilization for selected drugs in ATC class R03
• Analysis of drug policy tools in public health insurance resources utilization for selected drugs in diabetes mellitus treatment
• Analysis of drug policy tools in public health insurance resources utilization for selected oncology drugs
• Consumption analysis of ACT group drugs in geriatric population´s musculoskeletal system
• Herbal products used in special respiratory diseases
• Dispensation and advice of migraine in pharmacist´s practice
• Social Media Communication in Pharmaceutical Corporation
• Social Media Communication in Public Pharmacy
• Social Media Communication in Healthcare Providers
• Obesity and possibilities of its treatment
• The vaccination of elderly in Slovakia
• Continuous education of pharmacists in Slovakia
• Effects of excipients used in production of drugs
• The role of pharmacists in patients's education

Rigorous theses

• Biological treatment of idiopathic arthritis in childhood
• Chemotherapy of kidney cancer in childhood
• Interactions of cardiovascular drugs with fruits of the genus Citrus
• Clinical pharmacy aspects of influenza vaccination in community pharmacy

2019/2020

• Biological treatment of psoriasis and psoriasis arthritis
• Pharmaceutical care of geriatric patients
• Pharmacotherapy and supportive treatment in acute prostatis
• Medical prescriptions in European area
• Health status of patients with diabetes mellitus, intervention possibilities by health insurance company
• Student attitudes towards the use of addictive substances
• Patient compliance in asthma treatment
• Patient compliance in cystic fibrosis
• Patient compliance in chronic obstructive pulmonary disease
• Tetany - the modern disease of young people
• The role of pharmacists in the view of students attend pharmacy practice and in the view of patients
• Effect of electronic health care on current pharmacy's health care in the view of pharmacist and patient
• Impact of the Falsified Medicine Directive on the pharmaceutical sector
• Coenzyme Q derivates utilization in treatment of selected rare diseases
• Usage of new groups of drugs with cardiovascular benefits in treatment of type 2 diabetes mellitus

2018/2019

• Medicines pricing in European Union
• Crohn's disease and possibilities of its treatment
• Dispensing of drugs used in selected disorders of the gastrointestinal tract
• Electronic prescription in pharmaceutical practice
• Morbus Fabry and treatment options in Slovakia
• Drug interactions
• Clinical interactions fruits of plants of the genus Citrus L. with drugs
• Quality of life and its measuring in clinical practice
• Management of severe asthma
• Management of severe COPD by fix triple combination of drugs
• Patient organizations and their role in healthcare
• Peyment mechanisms in healthcare
• Risk of pharmacotherapy in geriatrics
• Ways of funding the pharmaceutical care system

2017/2018

• Biologic therapy of rheumatic inflammatory diseases in clinical practice
• Patient Compliance
• Dispensing of veterinary parasiticides in pharmacist´s practice
• Dispensing of selected veterinary drugs and preparations
• Access to Drugs for Orphan Diseases
• Prescription forgery and possibilities of its restriction
• Histamine intolerance and possibilities of its treatment
• Internet Pharmacy and self-service zones in pharmacy
• Clinical relevance of drug interactions
• Medicines in the environment
• Management of severe COPD by combination therapy
• Personal Management in Pharmacy
• Multiple sclerosis and possibilities of its treatment
• Over the counter products used for dry eye syndrome in pharmacy practice

2016/2017

• Efficiency analysis of the health technology assessment in Slovakia from budget impact perspective on public health insurance resources
• Analysis of health technology assessment effectiveness in Slovakia from budget impact perspective on public health funding of highly innovative drugs
• Enzyme replacement therapy of alphamanosidosis, rapid health technology assessment
• Pharmacovigilance, theory and practice in Slovak healthcare and pharmacy
• Gastroesophageal reflux in children
• Health Technology Assessment, theory and reality in Slovakia
• Drugs compounding in Slovak republic
• Inhaled corticosteroids in treating bronchial asthma
• Interaction of drugs increasing the risk of prolongation of QT interval
• Clinical utilization of probiotics in preventing and treating gastrointestinal disorders
• Legislative, organizational, material and technical, personal and economic conditions for establishing and operating the public pharmacy in Slovakia and selected EU countries
• Interactions of proton inhibitors
• Marketing communication in public pharmacy
• Oral microflora modification by products used in pharmacy
• Problems of prescription and dispensing of veterinary medicines in pharmacy practice
• Advantages of transdermal forms of hormone replacement therapy

2015/2016

• Analysis of the reimbursement mechanismes effectiveness in asthma treatment
• Analysis of the pharmaceutical industry e-marketing
• Analysis of pharmacological asthma treatment in Slovak population
• Analysis of the COPD treatment in Slovak population
• Physiological and health effects of plant phytoestrogens
• Health Technology Assessment in Europe and Slovakia
• Holoclar - the first registered stem cells therapy in EU
• Treatment and risks associated with therapy Hodgkin's disease and non - Hodgkin's lymphoma
• Orphan drugs
• Food contribute to the maintenance of normal blood cholesterol levels used in pharmaceutical practice
• Attitudes and interests of pharmacists regarding professional autonomy
• Continuing education of pharmacists in Slovak republic
• Effects of Lactobacillus reuteri and its use in pharmaceutical practice
• Nutritional supplements containing probiotics potential useful by allergic rhinitis

2014/2015

• Anticholinergic effect of drugs in elderly patients
• EU Cross-border healthcare Directive and its impact on pharmacy and pharmaceutics
• The dispensing algorithms
• Ethics in pharmaceutics and pharmacy
• Hormonal treatment of menstrual cycle disorders and risks of this treatment
• Immunotherapy of allergic diseases using probiotics and their utilization in pharmaceutical practice
• Pharmacy compounding in community pharmacy practice in Slovak republic
• Dispensing Drugs and Medical Supply via Internet
• Classification and use of dietetics in therapeutic practice
• Asthma treatment in adults
• Treatment of Chronic Obstructive Pulmonary Disease in Adults
• Pharmaceutical Industry Marketing within the Context of Slovak republic Legislation
• Adverse drug reaction specific to childhood
• Orphan Drugs in the treatment of rare diseases
• OTC medicines: The risk of drug interactions
• Veterinary probiotics in pharmaceutical practice
• Advertising impact on patients decision-making
• Pharmacist´s prick of conscience
• The use of antidotes in overdoses and poisoning with medicaments
• The use of medicinal oxygen in therapeutic practice
• The development of medicines for human use prescribing legislation in Slovak republic

2013/2014

• Acute infections of the upper respiratory tract (J00-J06) childhood
• Acute diseases of the urinary system, a children's age (N10, N30)
• Asthma in childhood, diagnostics and treatment
• Epilepsy in childhood, diagnostics and treatment
• Gene therapy, individual - personalized pharmacological interventions
• Other acute infections of the lower respiratory tract (J20-J22) childhood
• Prevention and treatment of gynecological inflammations using probiotics and their utilisation in pharmaceutical practice
• Cervical cancer in women and its prevention
• Group B-medical devices for incontinence, urine retention
• Group F-medical devices for patients with stomia
• Group L-Carts and carriages, mobile handcart, jacks, a special bed and accessories to them sick
• The impact of food and fluid on the occurrence of adverse effects of medicinal products
• Selected marketing methods in the pharmaceutical practice

2012/2013

• Pharmacotherapy of alopecia (L60-L66.9) and its risks
• Pharmacotherapy of bacterial pneumonia (J13 - J15)
• Pharmacotherapy of bacterial diseases in children (A36, A37, A38, A39)
• Pharmacotherapy of viral diseases in children (B01, B03, B04, B05 a B06)
• Pharmacotherapy of inner ear (H80-H83) and its risks
• Pharmacotherapy of epilepsy
• Hypericum perforatum effect, pharmacokinetics
• Options of pharmacotherapy in colorectal cancer
• Options of using probiotics during antibiotic treatment
• Options of using nutritional supplements for arthropathy
• Nutritional supplements for diabetics
• Nutritional supplements containing probiotics and their use in pharmacy practice